The Rosnano Foundation together with the American company Solix Algredients opened a research center for the transfer of biotechnologies for growing microalgae at the site of the Russian State University of Oil and Gas. Gubkin.

The research center "Solix BioSystems Vostok" will study strains from Russian collections in order to create an experimental-industrial production of food additives, antibiotics and antioxidants. Microalgae are natural biofactories of high value added biologically active substances.
According to the company's CEO Denis Kuzmin, global sales of some microalgae products reach billions of dollars. In Russia, the market for medicinal cosmetics is estimated at one billion dollars.
')
The key element of the technological chain is the
photobioreactor Lumian AGS260 . It is already installed on the site of the University. Gubkin. An international team of researchers has been assembled to work in the laboratory.
Solix BioSystems Vostok is a 100% subsidiary of the American Solix Algredients, which is included in the portfolio of the I2BF-RNC Resources Fund, which is invested by the Rosnano Fund. Solix Algredients
invests five million dollars in the Russian R & D center.